pmid,title,journal,year,drug,disease
38051858,Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases.,Journal of drugs in dermatology : JDD,2023,Baricitinib,Crohn's Disease
36403719,Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update.,Pharmacological research,2023,Baricitinib,Crohn's Disease
33188136,Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.,RMD open,2020,Baricitinib,Crohn's Disease
31862477,Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update.,Pharmacological research,2020,Baricitinib,Crohn's Disease
30877063,Properties of FDA-approved small molecule protein kinase inhibitors.,Pharmacological research,2019,Baricitinib,Crohn's Disease
28765121,"Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?",Annals of the rheumatic diseases,2018,Baricitinib,Crohn's Disease
27473820,Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases.,Pharmacological research,2016,Baricitinib,Crohn's Disease
